RT Journal Article
SR Electronic
T1 Environmental indicator for effective control of COVID-19 spreading
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.12.20099804
DO 10.1101/2020.05.12.20099804
A1 Lian, Xinbo
A1 Huang, Jianping
A1 Zhang, Li
A1 Liu, Chuwei
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.12.20099804.abstract
AB Recently, a novel coronavirus (COVID-19) has caused viral pneumonia worldwide, spreading to more than 200 countries, posing a major threat to international health. To prevent the spread of COVID-19, in this study, we report that the city lockdown measure was an effective way to reduce the number of new cases, and the nitrogen dioxide (NO2) concentration can be adopted as an environmental lockdown indicator. In China, after strict city lockdown, the average NO2 concentration decreased 55.7% (95% confidence interval (CI): 51.5-59.6%) and the total number of confirmed new cases decreased significantly. We also determined that the global airborne NO2 concentration steeply decreased over the vast majority of COVID-19-hit areas based on satellite measurements. We found that if NO2 emissions significantly decreased, the total number of confirmed new cases reached an inflection point after approximately two weeks. Italy, Germany and France are good examples. Our results suggest that NO2 satellite measurement can help decision makers effectively monitor control regulations to reduce the spread of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was jointly supported by the National Science Foundation of China (41305009 and 41405010).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used during the study were provided by a third party. (List items). Direct requests for these materials may be made to the provider. https://disc.gsfc.nasa.gov/datasets/OMNO2d_003 http://www.cnemc.cn/.https://github.com/CSSEGISandData/COVID-19